We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
-2.2%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$169M
AUM Growth
-$4.66M
Cap. Flow
+$2.74M
Cap. Flow %
1.62%
Top 10 Hldgs %
73.61%
Holding
610
New
35
Increased
156
Reduced
72
Closed
36

Top Buys

Rank Stock Value
1
ANAB icon
AnaptysBio
ANAB
+$1.53M
2
CNTA
Centessa Pharmaceuticals
CNTA
+$1.14M
3
AXGN icon
Axogen
AXGN
+$586K
4
TSLA icon
Tesla
TSLA
+$504K
5
PLRX icon
Pliant Therapeutics
PLRX
+$501K

Top Sells

Rank Stock Value
1
FNA
Paragon 28, Inc.
FNA
+$1.36M
2
NVDA icon
NVIDIA
NVDA
+$517K
3
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$409K
4
IWM icon
iShares Russell 2000 ETF
IWM
+$252K
5
PYCR
Paycor HCM, Inc. Common Stock
PYCR
+$144K

Sector Composition

Rank Sector Weight
1 Healthcare 15.33%
2 Financials 5.86%
3 Technology 3.53%
4 Industrials 1.51%
5 Consumer Discretionary 1.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INVH icon
376
Invitation Homes
INVH
$17.7B
$4.74K ﹤0.01%
136
-102
-43% -$3.29K
LDOS icon
377
Leidos
LDOS
$14.5B
$4.72K ﹤0.01%
35
– –
KMX icon
378
CarMax
KMX
$8.13B
$4.67K ﹤0.01%
+60
New +$4.81K
HOOD icon
379
Robinhood
HOOD
$77.8B
$4.65K ﹤0.01%
+112
New +$5.33K
TW icon
380
Tradeweb Markets
TW
$21.4B
$4.6K ﹤0.01%
31
+8
+35% +$1.06K
MEDX icon
381
Horizon Kinetics Medical ETF
MEDX
$17.3M
$4.57K ﹤0.01%
165
– –
KKR icon
382
KKR & Co
KKR
$91.1B
$4.39K ﹤0.01%
38
+30
+375% +$4.13K
WAB icon
383
Wabtec
WAB
$49.1B
$4.35K ﹤0.01%
24
-20
-45% -$3.83K
NBIX icon
384
Neurocrine Biosciences
NBIX
$16.8B
$4.31K ﹤0.01%
39
– –
MLM icon
385
Martin Marietta Materials
MLM
$31.5B
$4.3K ﹤0.01%
9
– –
NVO
386
Novo Nordisk
NVO
$208B
$4.25K ﹤0.01%
61
+5
+9% +$413
UL icon
387
Unilever
UL
$137B
$4.17K ﹤0.01%
62
– –
RELX icon
388
RELX
RELX
$61.8B
$4.16K ﹤0.01%
83
+9
+12% +$440
SPYI icon
389
NEOS S&P 500 High Income ETF
SPYI
$10.8B
$4.16K ﹤0.01%
+87
New +$4.4K
GNTX icon
390
Gentex
GNTX
$4.97B
$4.09K ﹤0.01%
176
+1
+0.6% +$26
GERN icon
391
Geron
GERN
$828M
$4.01K ﹤0.01%
2,525
+750
+42% +$1.83K
CART icon
392
Maplebear
CART
$10.5B
$3.99K ﹤0.01%
100
– –
ETR icon
393
Entergy
ETR
$50.2B
$3.94K ﹤0.01%
46
– –
INDA icon
394
iShares MSCI India ETF
INDA
$6.89B
$3.89K ﹤0.01%
76
– –
AA icon
395
Alcoa
AA
$11.9B
$3.87K ﹤0.01%
127
+53
+72% +$1.86K
NWG icon
396
NatWest
NWG
$75.3B
$3.79K ﹤0.01%
318
– –
DLTR icon
397
Dollar Tree
DLTR
$24.4B
$3.75K ﹤0.01%
+50
New +$3.58K
EXC icon
398
Exelon
EXC
$46.9B
$3.73K ﹤0.01%
+81
New +$3.39K
BCYC
399
Bicycle Therapeutics
BCYC
$269M
$3.69K ﹤0.01%
435
-4,000
-90% -$47.1K
BCS icon
400
Barclays
BCS
$92.7B
$3.68K ﹤0.01%
239
– –
14 15
16
17 18

Similar funds

IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return
KC
Kinloch Capital Glen Allen, Virginia $245M AUM 18.26% 1-Year Est. Return
HA
Hanover Advisors Seneca, South Carolina $246M AUM 12.74% 1-Year Est. Return

HighMark Wealth Management's Q1 2025 Portfolio in Review

As of Q1 2025, HighMark Wealth Management held 610 positions worth $169M, down 2.7% from $174M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

HighMark Wealth Management's Q1 2025 filing shows 35 new, 156 increased, 72 reduced and 36 closed positions. Its largest new stake was AnaptysBio: 92,000 shares worth $1.71M. The largest sale was Paragon 28, Inc., an estimated $1.36M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

  • HighMark Wealth Management's largest Q1 2025 buy was AnaptysBio: 92,000 shares worth $1.71M.
  • HighMark Wealth Management added most to Centessa Pharmaceuticals in Q1 2025, an estimated $1.14M increase.
  • HighMark Wealth Management's biggest Q1 2025 reduction was Paragon 28, Inc., cutting an estimated $1.36M.
  • HighMark Wealth Management fully exited Paycor HCM, Inc. Common Stock in Q1 2025, selling an estimated $144K.
  • HighMark Wealth Management's ten largest holdings make up 74% of its $169M portfolio in Q1 2025.
  • HighMark Wealth Management opened 35 new positions and closed 36 in Q1 2025.
  • HighMark Wealth Management's portfolio value fell 2.7% quarter-over-quarter to $169M.

Based on HighMark Wealth Management's 13F filing for Q1 2025, filed 24 Apr 2025.